Reports new positive interim data from the ongoing Phase 1 study of BHV-1300, Biohaven s lead investigational drug from its Molecular Degrader of Extracellular.
Royalty Pharma : Q1 2024 Press Release - MarketScreener marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Cortechs.ai, a pioneer in AI-driven healthcare solutions, proudly announces a major update for its flagship product, NeuroQuant® v5.0, which is currently FDA 5
BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.